Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.
Sportschosun on MSN6d
Lee Hyun-yi, testing for cerebrovascular disease..I don't know if the result is bad or bad. (Act 2)Lee Hyun-yi received a test result saying she should be careful of cerebrovascular disease.SBS 'Act 2 of Life from Today', which will be broadcast on the 29th, points out the world's unchanging number ...
Compared with the use of other migraine medications, use of erenumab did not increase cardiovascular or cerebrovascular risks.
Hosted on MSN14d
Sonolysis Reduces Risk for Periprocedural Cerebrovascular Events During Carotid Endarterectomy"Sonolysis should be used to reduce the risk of periprocedural cerebrovascular events during carotid endarterectomy in all patients with sufficient temporal bone window for transcranial Doppler," the ...
However, not all aneurysms are high risk to rupture and it is important to speak with a cerebrovascular neurosurgeon about your particular aneurysm. The cerebrovascular neurosurgeons at Baylor ...
Though Alzheimer's disease is often described as a buildup of proteins in the brain in the form of plaques and tangles, a new ...
Our division specializes in the prevention, diagnosis and treatment of stroke and stroke-related disorders through the Comprehensive Stroke Research Center, with a 24-7-365 stroke team and ...
Considering taking supplements to treat cerebrovascular disease? Below is a list of common natural remedies used to treat or reduce the symptoms of cerebrovascular disease. Follow the links to ...
Brain AVMs are rare, but once discovered, it is important to have them evaluated by a doctor with expertise in brain vessels such as a cerebrovascular neurosurgeon. The cerebrovascular neurosurgeons ...
Researchers will test a web-based software, Mobile Rehab, which delivers personalized exercises for stroke telerehabilitation ...
Survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis have an increased risk of cardiovascular mortality in the year after diagnosis.
BioCardia (BCDA) announced two-year outcomes from the double-blind randomized placebo-controlled Phase 3 CardiAMP-HF study of its CardiAMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results